CVE-2019-5024
CVE-2019-5024 is a high-severity vulnerability in Capsuletech Smartlinx Neuron 2 Firmware with a CVSS 3.x base score of 7.6. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-693.
Key facts
- Severity: High (CVSS 3.x base score 7.6)
- CVSS v2: 7.2
- EPSS exploit prediction: 0% (38th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-693
- Affected product: Capsuletech Smartlinx Neuron 2 Firmware
- Published:
- Last modified:
Description
A restricted environment escape vulnerability exists in the “kiosk mode” function of Capsule Technologies SmartLinx Neuron 2 medical information collection devices running versions 9.0.3 or lower. A specific series of keyboard inputs can escape the restricted environment, resulting in full administrator access to the underlying operating system. An attacker can connect to the device via USB port with a keyboard or other HID device to trigger this vulnerability.
Frequently asked questions
- What is CVE-2019-5024?
- A restricted environment escape vulnerability exists in the “kiosk mode” function of Capsule Technologies SmartLinx Neuron 2 medical information collection devices running versions 9.0.3 or lower. A specific series of keyboard inputs can escape the restricted environment, resulting in full administrator access to the underlying operating system. An attacker can connect to the device via USB port with a keyboard or other HID device to trigger this vulnerability.
- How severe is CVE-2019-5024?
- CVE-2019-5024 has a CVSS 3.x base score of 7.6, rated high severity. It is exploitable over physical access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
- Is CVE-2019-5024 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (38th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2019-5024?
- CVE-2019-5024 affects Capsuletech Smartlinx Neuron 2 Firmware. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2019-5024?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- When was CVE-2019-5024 published?
- CVE-2019-5024 was published on 2019-04-11 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:o:capsuletech:smartlinx_neuron_2_firmware:*:*:*:*:*:*:*:*
Other CWE-693 (Protection Mechanism Failure) vulnerabilities
- CVE-2026-47140 — Critical (CVSS 10.0): vm2 is an open source vm/sandbox for Node.js. Prior to version 3.11.4, NodeVM blocks several dangerous Node.js builtins…
- CVE-2026-34208 — Critical (CVSS 10.0): SandboxJS is a JavaScript sandboxing library. Prior to 0.8.36, SandboxJS blocks direct assignment to global objects…
- CVE-2026-34938 — Critical (CVSS 10.0): PraisonAI is a multi-agent teams system. Prior to version 1.5.90, execute_code() in praisonai-agents runs…
- CVE-2026-2761 — Critical (CVSS 10.0): Sandbox escape in the Graphics: WebRender component. This vulnerability was fixed in Firefox 148, Firefox ESR 115.33,…
- CVE-2022-32845 — Critical (CVSS 10.0): This issue was addressed with improved checks. This issue is fixed in watchOS 8.7, iOS 15.6 and iPadOS 15.6, macOS…
- CVE-2026-45102 — Critical (CVSS 9.9): OneUptime is an open-source monitoring and observability platform. Prior to 10.0.98, OneUptime uses the Node.js' vm…
Browse all CWE-693 (Protection Mechanism Failure) vulnerabilities →